Skip to main content
. 2015 Feb 9;33(8):944–951. doi: 10.1200/JCO.2014.59.0026

Fig A2.

Fig A2.

Discriminatory performance of genomic classifier (GC) compared with Stephenson nomogram. (A) GC has the highest survival concordance index compared with clinical models at 5 years after radiotherapy (RT). (B) Decision curve analysis for 5-year post-RT metastasis prediction shows that models including GC have the highest net benefit across 0% to 25% threshold probabilities.